Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Danlou tablets plus Salvia miltiorrhiza ligustrazine injection in chronic stable angina
ChiCTR1900025601Phase 4Completed
- Sponsor
- Traditional Chinese Medicine Hospital of Tailai County
- Start
- Jan 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of danlou and salvia miltiorrhiza + ligustrazine injection in angina pectoris (2 arms), sponsored by Traditional Chinese Medicine Hospital of Tailai County. Primary endpoint: IL-1β. Started Jan 2019; status: completed.
02
Drugs
danlousalvia miltiorrhiza + ligustrazine injection
03
Conditions
angina pectoris
Beyond the preview
Go deeper on ChiCTR1900025601.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900025601.